why choose us

Clinical Trials Search

Showing 7,630 of 132,656 result(s)
IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Status: Completed

Condition: Inflammatory Bowel Diseases

Interventions: Light therapy via the Re-Timer.
Participants will conduct light treatment in the mornings at home for one hour using Re-timer®.

Date: 2023-10-16

Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects

Status: Completed

Condition: Healthy Adult Subjects

Interventions: 1 single oral dose of 90 mg TTYP01 (3 tablets of the test drugs, test formulation T)

Date: 2023-10-16

Palbociclib and Pembrolizumab in Undifferentiated Pleomorphic Sarcoma (UPS)

Status: NOT_YET_RECRUITING

Condition: Undifferentiated Pleomorphic Sarcoma

Interventions:

Palbociclib is a CDK4;6 inhibitor.

Palbociclib, 125 mg, (pediatric dose 75mg;m2 up to 125mg) daily for 21 days out of every 28 days

Date: 2023-10-16

Contribution of the Evaluation of Body Composition by Connected Scale in the Effectiveness of a Reconditioning Program Through Physical Activity Adapted for Patients Suffering From Chronic Diseases

Status: NOT_YET_RECRUITING

Condition: Chronic Disease

Interventions: Patients in the intervention group will use the connected scale at a minimum frequency of once a week from receipt of the scale and throughout their p

Date: 2023-10-16

Hyper-Spectral Endoscopy for Detection of Early Neoplasia in Barrett's Oesophagus

Status: NOT_YET_RECRUITING

Condition: Endoscopy

Interventions: We have developed a custom hyperspectral endoscopy approach based around a commercially available endoscopy system.
An Olympus gastroscope (GIF-H

Date: 2023-10-16

Influence of Gastric Tube Presence in Upholding the Correct Placement of LMA Blockbuster

Status: COMPLETED

Condition: Anesthesia

Interventions: In this study we wish to evaluate weather gastric tube inserted through LMA helps in maintaining the LMA blockbuster placement by comparing fibreoptic

Date: 2023-10-16

A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

Status: COMPLETED

Condition: Atopic Dermatitis

Interventions: subcutaneous injection every 2 weeks

Date: 2023-10-16

Paracervical Pouch in Placenta Accreta Spectrum

Status: COMPLETED

Condition: Placenta Accreta

Interventions:

Date: 2023-10-16

Management of Shoulder Dystocia in Flipped Learning

Status: COMPLETED

Condition: Shoulder Dystocia - Delivered

Interventions: flipped learning training group.
Applying a flipped learning model in addition to routine training in a fully equipped simulation

Date: 2023-10-16

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

Status: COMPLETED

Condition: Non-small Cell Lung Cancer

Interventions: DRUG: Tislelizumab IV - Planned doses will be administered intravenously.
DRUG: Tislelizumab SC - Planned doses will be administered via subcutan

Date: 2023-10-16